May 17th 2022, 5:29:58 pm | +/- | % | Buy | Sell | Last | High | Low | Volume |
ENZY (Stockholm) SEK/share | - | -2.79% | 4.67 | 4.70 | 4.70 | 4.98 | 4.51 | 29221 |
At the end of 2021, the share capital of Enzymatica AB was SEK 5 972 977 SEK, distributed among 149 324 400 shares, each with a par value of SEK 0.04.
The Company has only one class of stock. Each share entitles the holder to one vote at Enzymatica’s general meeting of shareholders. Each shareholder who is entitled to vote may vote at the general meeting for the full number of shares that he or she owns and represents. Each share carries equal rights to a part of the Company’s assets and profit.
The Board of Directors does not intend to propose any dividend until the Company generates a profit and a positive cash flow.
The number of shareholders at year-end 2021 was 8420, a decrease with 12% compared to 2020.
Name | Number of shares | Percentage of capital and votes (%) |
Mats Andersson, privately and through Abanico Invest AB | 31 081 437 | 20,8% |
Håkan Roos, through Roosgruppen AB | 19 029 461 | 12,7% |
Björn Algkvist through Fibonacci Asset Management | 16 227 416 | 10,9% |
Gudmundur Palmason, through Fortus hf company | 7 142 496 | 4,8 % |
Ágústa Gudmundsdottir, privately and through company | 5 190 679 | 3,5% |
Aktiebolaget Possessor | 3 800 000 | 2,5% |
Nordnet Pensionsförsäkring AB | 3 798 272 | 2,5% |
Avanza Pension Försäkring AB | 3 213 875 | 2,2 % |
Swedbank Försäkring | 2 360 215 | 1,6% |
Bengt Baron | 2 324 408 | 1,6% |
Holdings 10 largest shareholders | 94 168 259 | 63,1% |
Other | 55 156 141 | 36,9 % |
Total | 149 324 400 | 100,0% |
Euroclear 31 mars 2022
During the year Enzymatica was analyzed by ABG Sundal Collier and Erik Penser Bank.
Rickard Anderkrans ABG Sundal Collier: rickard.anderkrans@abgsc.se
Johan Löchen, Penser: johan.lochen@penser.se